Amicus Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FOLD and other ETFs, options, and stocks.About FOLD
Amicus Therapeutics, Inc. is a biotechnology company, which focuses on discovering, developing, and delivering medicines for people living with metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio.
CEOBradley Lewis Campbell
CEOBradley Lewis Campbell
Employees499
Employees499
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2002
Founded2002
Employees499
Employees499
FOLD Key Statistics
Market cap2.38B
Market cap2.38B
Price-Earnings ratio-63.10
Price-Earnings ratio-63.10
Dividend yield—
Dividend yield—
Average volume3.87M
Average volume3.87M
High today—
High today—
Low today—
Low today—
Open price$8.01
Open price$8.01
Volume0.00
Volume0.00
52 Week high$12.65
52 Week high$12.65
52 Week low$5.51
52 Week low$5.51
FOLD News
Simply Wall St 7d
Amicus Therapeutics Is Up 5.1% After Positive Four-Year Pompe Disease Study Results – What's ChangedAmicus Therapeutics recently presented new four-year efficacy and safety data from the PROPEL open-label extension study of cipaglucosidase alfa-atga plus miglu...
Analyst ratings
83%
of 12 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own FOLD. This list is generated using Robinhood data, and it’s not a recommendation.